retatrutide and cagrilintide blend retatrutide-and-cagrilintide-15mg-5mg Retatrutide 12.5mg + Cagrilintide 2.5mg

Some patients use maintenance protocols for ongoing digestive support

Why is AOD-9604 supplied as a lyophilized powder rather than a pre-mixed solution

Peptide Blend Vials (12 mg each): 8 weeks (~11.2 mL total): 4 vials 12 weeks (~16.8 mL total): 6 vials 16 weeks (~22.4 mL total): 8 vials Insulin Syringes (U100): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution

The maintenance frequency approach where intensive initial treatment transitions to reduced ongoing application (2-4 times weekly) provides middle ground sustaining benefits while minimizing costs and commitment intensity